SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000819050-22-000166
Filing Date
2022-11-14
Accepted
2022-11-10 19:19:43
Documents
65
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q frtx-20220930.htm   iXBRL 10-Q 1391415
2 EX-3.2 a2022093010qex32.htm EX-3.2 106767
3 EX-10.1 a2022093010qex101.htm EX-10.1 164631
4 EX-10.2 a2022093010qex102.htm EX-10.2 80994
5 EX-10.3 a2022093010qex103.htm EX-10.3 41235
6 EX-10.4 a2022093010qex104.htm EX-10.4 50702
7 EX-10.5 a2022093010qex105.htm EX-10.5 49420
8 EX-10.6 a2022093010qex106.htm EX-10.6 30527
9 EX-10.7 a2022093010qex107.htm EX-10.7 21779
10 EX-31.1 a2022093010qex311.htm EX-31.1 10125
11 EX-31.2 a2022093010qex312.htm EX-31.2 9886
12 EX-32.1 a2022093010qex321.htm EX-32.1 8966
18 frtx-20220930_g1.jpg GRAPHIC 166788
  Complete submission text file 0000819050-22-000166.txt   6260247

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT frtx-20220930.xsd EX-101.SCH 40222
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT frtx-20220930_cal.xml EX-101.CAL 34608
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT frtx-20220930_def.xml EX-101.DEF 176790
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT frtx-20220930_lab.xml EX-101.LAB 427438
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT frtx-20220930_pre.xml EX-101.PRE 279246
59 EXTRACTED XBRL INSTANCE DOCUMENT frtx-20220930_htm.xml XML 668442
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21088 | Film No.: 221379130
SIC: 2836 Biological Products, (No Diagnostic Substances)